Given the significant roles of GLS1 and methylation modifications in regulating glutamine energy metabolism, targeting the activities of methylation‐modifying enzymes and their upstream regulators may present a promising strategy for influencing glutamine catabolism in CRC. This evidence concerns the gene GLS and colorectal carcinoma.